摘要
目的探讨在我院第三门诊部对糖尿病患者进行有效路径干预治疗后,分析门诊部2009～2011年降糖药物的使用情况,为降低糖尿病的并发症、急诊率、住院率,和提高糖尿病临床合理用药提供一些参考。方法采用金额排序法和DDD分析法,对我门诊部2009～2011年度降糖药的用药金额、糖尿病药品所占总药品金额的比例、用药频度(DDDs)、日均费用(DDC)等进行统计与分析。结果 2009～2011年降糖药的品种、数量及销售金额等逐年增长;我门诊部用药金额前3位为阿卡波糖、30R胰岛素、那格列奈;用药频度前3位为阿卡波糖、30R胰岛素、格列齐特;日均费用前3位为30R胰岛素、R胰岛素、N胰岛素。结论对我门诊182例糖尿病患者建立观察病历,对178例糖尿病患者治疗前后进行对比,在对糖尿病患者有效路径干预后,降低了临床药占比例,节省了医疗资源。糖尿病干预前、后对比,糖尿病患者并发症、急诊率、住院率明显下降,两组之间差异有统计学意义。我门诊部降糖药路径干预后的应用较为合理。医生开具的处方能够从患者的病情需要出发,真正做到用药经济、安全、合理、有效。
Objective Analysis of hypoglycemic drugs used in our clinic from 2009 to 2011 is discussed after efficient paths intervention therapy for diabetic patients, which can provide references for deceasing the occurrence of diabetic complication, emergency, hospitalization rate and improving rational clinical drug use on diabetic. Methods Statistics and analysis of the cost of antidiabetic drugs, the proportion of antidiabetic drugs, DDDs, DDc and so on in our clinic from 2009 to 2011 are made by the methods of ranking of amount of money and DDD analysis. Results The variety, number and consumption sum of antidiabetic drugs are increasing year by year from 2009 to 2011. Acarbose,30R insulin and nateglinide rank the first three places in drug consumption sum; acarbose, 30R insulin and gliclazide rank the first three places in DDDs; 30R insulin, Rinsulin and N insulin rank the first three places in daily cost. Conclusions We establish observation medical record for 182 patients with diabetes in community. And we make comparison for 178 diabetic patients between before therapy and after therapy. After intervention therapy, Clinical Pharmacology＇s use rate decrease apparently and medical resources are saved. And also diabetic complication, emergency and hospitalization rate reduce significiantly after intervention therapy. There is significant statistical significance between data before and after intervention therapy. The use of antidiabetic drugs after paths intervention therapy is reasonable in our clinic. Doctor＇s prescription can fulfill patient＇s disease treatment, which predicts economic, safety, reasonable and effective in drug use.
出处
《中国药物警戒》
2012年第8期492-495,共4页
Chinese Journal of Pharmacovigilance
关键词
糖尿病
路径干预
降糖药物
分析观察
合理用药
diabetes
path intervention
antidiabetic drugs
analysis and observation
rational use of drugs
